Evoke Pharma(US:EVOK) Benzinga·2025-11-04 17:46Market Overview - U.S. stocks experienced a decline, with the Nasdaq Composite falling over 350 points, Dow down 0.60% to 47,053.04, NASDAQ down 1.65% to 23,441.48, and S&P 500 down 1.05% to 6,780.03 [1] - Financial shares increased by 0.4%, while information technology stocks decreased by 1.8% [1] Company Performance - Uber Technologies reported a 20% year-over-year revenue growth to $13.47 billion, exceeding analyst expectations of $13.28 billion, and adjusted EPS of 81 cents, beating the consensus estimate of 69 cents [2] - Evoke Pharma shares surged 133% to $10.71 following an acquisition agreement with QOL Medical [8] - PTL Limited shares rose 49% to $0.28 after reporting a year-over-year increase in H1 EPS results [8] - Denny's Corporation shares increased by 50% to $6.16 after announcing an all-cash acquisition deal valued at approximately $620 million, or $6.25 per share [8] - Norwegian Cruise Line Holdings Ltd shares fell 15% to $18.86 after missing third-quarter revenue expectations [8] - JELD-WEN Holding, Inc. shares dropped 28% to $3.01 due to worse-than-expected third-quarter results and a lowered FY25 guidance [8] - Sarepta Therapeutics Inc shares declined 31% to $16.82 after reporting disappointing third-quarter results and a failed clinical study [8] Commodity Market - Oil prices decreased by 0.5% to $60.77, gold fell by 1.1% to $3,970.20, silver dropped 1.5% to $47.345, and copper fell 2.5% to $4.9450 [5] European Market - European shares were mostly lower, with the eurozone's STOXX 600 declining 0.30%, while Spain's IBEX 35 Index fell 0.01%, London's FTSE 100 rose 0.14%, Germany's DAX 40 dipped 0.76%, and France's CAC 40 fell 0.52% [6] Asian Market - Asian markets closed lower, with Japan's Nikkei 225 down 1.74%, Hong Kong's Hang Seng down 0.79%, China's Shanghai Composite down 0.41%, and India's BSE Sensex down 0.62% [7] Economic Indicator - The Logistics Manager's Index remained unchanged at 57.4 in October, matching the previous month's reading [9]